Assessing Differences in How the CushingQoL Is Interpreted Across Countries: Comparing Patients From the U.S. and the Netherlands

Documenti analoghi

• Mapping CushingQoL Scores onto SF-6D Utility Values in Patients with Cushing’s Syndrome
  di: Roset, Montse, et al.
  Pubblicazione: (2013)
• The U.S. Health System and Immigration: An Institutional Interpretation()
  di: Portes, Alejandro, et al.
  Pubblicazione: (2009)
• The performance of the IES-R for Latinos and non-Latinos: Assessing measurement invariance
  di: Tiemensma, Jitske, et al.
  Pubblicazione: (2018)
• Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing’s syndrome (ERCUSYN)
  di: Badia, X., et al.
  Pubblicazione: (2013)
• Very high and low residual spenders in private health insurance markets: Germany, The Netherlands and the U.S. Marketplaces
  di: McGuire, Thomas G., et al.
  Pubblicazione: (2020)